FDA Inspection 911875 — Rising Son, Inc
The FDA completed an inspection of Rising Son, Inc on January 12, 2015 in Anoka, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 12, 2015
- Fiscal Year
- 2015
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Anoka, MN (United States)